Dudediligence.

Biogen Inc

BIIBNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
OptionsOpen the Sheet →FilingsNewest: 10-Q, Quarterly reportJul 29 →Insiders1 insider bought $585 in 1 open-market buy. 1 insider sold $665,664, all 2 sales on a 10b5-1 plan.→HoldersFMR 12.4%BlackRock 10.9%Primecap Management Co/ca/ 10.3%→Financing →PeersClosest companies: AMGN, INCY, VRTX→

From the filings

Figures

Revenue
$10.03Blast 12 months
Net income
$834.7Mlast 12 months
Operating cash flow
$2.59Blast 12 months
Cash and equivalents
$1.28Bat the last balance sheet
Total debt
$7.29Bat the last balance sheet
Shares outstanding
146.8M shareson issue
Every year and quarter →